The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation

Clinical trial NCT06843551 · RECRUITING

Trial details

NCT number: NCT06843551
Sponsor: Benjamin Spieler
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Ductal Adenocarcinoma Metastatic Pancreatic Cancer

Start date: 2025-06-18
Primary completion: 2030-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.